Search

Hutchison China MediTech Ltd ADR

Chiusa

SettoreSettore sanitario

14.49 0.07

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

14.08

Massimo

14.7

Metriche Chiave

By Trading Economics

Entrata

-8.9M

-8M

Vendite

3.7M

139M

P/E

Media del settore

141.3

56.254

Margine di Profitto

-5.724

Dipendenti

1,790

EBITDA

18M

4M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+18.96% upside

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

544M

2.5B

Apertura precedente

14.42

Chiusura precedente

14.49

Notizie sul Sentiment di mercato

By Acuity

50%

50%

107 / 339 Classifica in Healthcare

Hutchison China MediTech Ltd ADR Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

30 set 2026, 23:42 UTC

News
Correlated Moves

Albertsons Companies Inc appointed Cody Perdue as Interim CFO and announced new board members, with shares trading higher in after-market hours.

30 set 2026, 23:41 UTC

News

Norwegian Cruise Line Holdings Ltd. has priced $950 million in senior notes due 2031, with shares modestly higher in after-market trading.

30 set 2026, 23:40 UTC

News

Apple Inc. is implementing organizational changes under CEO John Ternus, resulting in modestly higher shares during after-market hours.

30 set 2026, 23:40 UTC

News

MGIC Investment Corp's shares rose in after-market trading, recovering from recent declines amid ongoing sector pressures from rising mortgage rates and reduced housing demand.

30 set 2026, 23:35 UTC

News

Mattel's CEO, Ynon Kreiz, appointed co-CEO of the merged Paramount and Warner Bros. Discovery, as shares rise modestly in after-market trading.

30 set 2026, 23:35 UTC

News

Photronics Inc's shares traded roughly flat in after-market hours following its announcement to participate in the 18th Annual CEO Investor Summit on October 13th.

30 set 2026, 23:30 UTC

News
Event

Sarepta Therapeutics shares are trading higher in after-market hours following new data on ELEVIDYS presented at the World Muscle Society Congress.

30 set 2026, 23:26 UTC

News
Event
Social Media

Micron Technology Inc's stock fell in after-hours trading following its Q4 earnings report, despite exceeding revenue and EPS estimates, amid concerns over future guidance.

30 set 2026, 23:21 UTC

News

Standard BioTools Inc. agrees to sell its Mass Cytometry business to Element Biosystems, LLC for $5.5 million, boosting net cash by $15 million, shares rise in after-market trading.

30 set 2026, 23:15 UTC

News

Guidewire Software Inc has signed a multi-year agreement with a top 10 U.S. insurance carrier, leading to a modest increase in after-market trading.

30 set 2026, 23:15 UTC

News

Star Bulk Carriers Corp. is rising in after-market trading, supported by a significant increase in the Baltic Exchange’s dry bulk freight index.

30 set 2026, 23:11 UTC

Social Media
News

Rocket Lab Corporation secured a multi-year agreement for 20 Electron launches with Synspective, boosting its backlog to over 100 missions, driving higher after-market trading.

30 set 2026, 23:06 UTC

News

Visa Inc. is trading slightly higher in after-market hours, maintaining a position roughly flat since Wednesday's close amid limited movement and recent declines.

30 set 2026, 23:06 UTC

Event
Social Media
News

Eli Lilly's shares rose in after-market hours following positive Phase 3 ACHIEVE-4 trial results for Foundayo, showing lower cardiovascular risks compared to insulin glargine.

30 set 2026, 23:06 UTC

News

Lululemon Athletica Inc announced an extension with Chip Wilson to finalize a new director appointment, with shares slightly higher in after-market trading.

30 set 2026, 23:06 UTC

News
Social Media

Kodiak Sciences is higher in after-market trading following Baker Bros Advisors' acquisition of 715k shares for $63.4 million, raising their stake to 35%.

30 set 2026, 23:06 UTC

News
Correlated Moves

Delta Air Lines Inc. is trading modestly higher in after-market hours, supported by a quarterly dividend of $0.2150 per share and gains in major holdings.

30 set 2026, 23:05 UTC

News

Conagra Brands Inc declined in after-market trading, following its Q1 fiscal year 2027 earnings call that noted strong results but no immediate developments.

30 set 2026, 23:05 UTC

News

Verizon Communications Inc. is trading slightly higher in after-market hours, following CEO Dan Schulman's comments on advancements in artificial intelligence and an "AI-native" model.

30 set 2026, 23:05 UTC

Social Media
News

Boeing Co has secured an order from Ethiopian Airlines for ten 777 Freighters and received U.S. defense contracts totaling over $207 million, trading higher in after-market hours.

30 set 2026, 23:01 UTC

Social Media
News
Event

Vicor Corporation raised its Q3 2026 revenue growth guidance to over 30%, driven by increased royalties from its VPD technology, boosting shares in after-hours trading.

30 set 2026, 23:01 UTC

News
Event
Social Media

Progress Software shares fell in after-market trading after Q3 results showed revenue of $246 million missed estimates, despite adjusted EPS of $1.69 exceeding expectations.

30 set 2026, 23:01 UTC

News
Social Media

Liquidia Corp is appealing a court ruling on YUTREPIA patents, with shares modestly higher in after-market hours amid ongoing litigation challenges.

30 set 2026, 23:01 UTC

News
Social Media

United Therapeutics shares rose in after-market trading following a court ruling that Liquidia infringed on its patent claims for inhaled treprostinil treatments.

30 set 2026, 23:01 UTC

News

DoorDash Inc. has launched its delivery drone, DoorDash Air, set for pilot flights in Northern California, contributing to higher after-market trading shares.

30 set 2026, 23:01 UTC

Social Media
News

Constellation Energy Corp's after-hours stock rises following a 20-year power purchase agreement with Amazon, adding 190 megawatts of nuclear capacity and $3 billion in investments.

30 set 2026, 23:01 UTC

News
Event
Social Media

Synopsys projects fiscal year 2027 revenue of $11.15 billion and adjusted EPS of $19.04 to $19.12, trading higher in after-market hours.

30 set 2026, 23:01 UTC

Social Media
News

Nu Holdings Ltd. clarified it is not pursuing a $10.6B to $13.3B acquisition of Monzo, leading to a significant stock price increase in after-market hours.

30 set 2026, 23:01 UTC

Social Media
News

Madison Square Garden Sports Corp. announced a spin-off of its New York Rangers business, leading to a higher stock price in after-hours trading.

30 set 2026, 23:01 UTC

Social Media
News

NextEra Energy, in partnership with Related Companies and Lewis Energy, announced Project Star, a $22.3 billion energy campus in Texas, boosting shares higher in after-market hours.

Confronto tra pari

Modifica del prezzo

Hutchison China MediTech Ltd ADR Previsione

Obiettivo di Prezzo

By TipRanks

18.96% in crescita

Previsioni per 12 mesi

Media 16.833 USD  18.96%

Alto 18.5 USD

Basso 14 USD

Basato su 3 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Hutchison China MediTech Ltd ADR - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

3 ratings

2

Acquista

1

Mantieni

0

Vendi

Sentiment

By Acuity

107 / 339 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Hutchison China MediTech Ltd ADR

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in Hong Kong and internationally. The company develops Savolitinib for the treatment of non-small cell lung cancer (NSCLC), papillary renal cell carcinoma (RCC), and gastric cancer (GC); and Fruquintinib, an inhibitor for colorectal cancer (CRC), breast cancer, gastric cancer, microsatellite stable-CRC endometrial cancer (EMC), NSCLC, RCC, gastrointestinal, cervical, and solid tumors. It also develops Surufatinib, which is used for the treatment of pancreatic neuroendocrine tumor (NET), non-pancreatic NET, neuroendocrine carcinoma, SCLC, biliary tract cancer, and solid tumors; and Sovleplenib that treats hematological cancers and certain chronic immune diseases. In addition, it develops Tazemetostat for the treatment of certain epithelioid sarcoma and follicular lymphoma patients; HMPL-306, an inhibitor for hematological malignancies, gliomas, chondrosarcomas, cholangiocarcinomas, and solid tumors; HMPL-760, a Bruton's tyrosine kinase inhibitor; HMPL-453 for intrahepatic cholangiocarcinoma and solid tumors; HMPL-295 and HMPL-415 for solid tumors; HMPL-653 for metastatic solid tumors and tenosynovial giant cell tumors; and HMPL-A83 for the treatment of malignant neoplasms. It has collaboration agreements with AstraZeneca AB (publ), Lilly (Shanghai) Management Company Limited, Takeda, BeiGene Ltd., Inmagene Biopharmaceuticals Co. Ltd., Innovent Biologics Co., Inc., Genor Biopharma Co. Ltd., Shanghai Junshi Biosciences Co. Ltd., and Epizyme, Inc. The company was formerly known as Hutchison China MediTech Limited and changed its name to HUTCHMED (China) Limited in May 2021. HUTCHMED (China) Limited was incorporated in 2000 and is headquartered in Hong Kong, Hong Kong.